Gilbert Gorr

As Chief Scientific Officer and Head of R&D, Dr. Gilbert Gorr is responsible for all development projects regarding new plant-based cell cultures. In addition, he leads the technical support of Phyton Biotech’s patent prosecution processes, as well as the identification, preparation, and filing of new patent applications. In 2009, Gilbert cofounded Emcid Biotech GmbH where he served as managing director and CSO until realizing a successful exit in 2013.

Prior to Emcid, Gilbert served as CSO of Greenovation Biotech where he was also a shareholder. Gilbert is the inventor/co-inventor of 11 patent families comprising of secondary metabolites produced by plant cell cultures, expression technologies, molecular tools, and glycoengineering – including antibody optimization. So far, his work has resulted in more than 250 granted patents and numerous scientific publications.

During his career with his teams and multi-national collaborators, Gilbert has been successful in securing research grants funded by state, federal, and international organizations such as the German Federal Ministry of Education and Research, the European Union, and the Bill & Melinda Gates Foundation.

After receiving his doctorate degree in natural sciences at Hamburg University for his work on the moss bioreactor/BryoTechnology, Gilbert was Post Doc at the School of Veterinary Medicine Hannover where he worked in the area of pharmaceutical development with a special emphasis on dermatology.